BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 38574835)

  • 21. In vivo and in vitro effect of novel 4,16-pregnadiene-6,20-dione derivatives, as 5alpha-reductase inhibitors.
    Bratoeff E; Cabeza M; Pérez-Ornelas V; Recillas S; Heuze I
    J Steroid Biochem Mol Biol; 2008 Sep; 111(3-5):275-81. PubMed ID: 18644453
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Suppression of steroid 5α-reductase type I promotes cellular apoptosis and autophagy via PI3K/Akt/mTOR pathway in multiple myeloma.
    Dou R; Qian J; Wu W; Zhang Y; Yuan Y; Guo M; Wei R; Yang S; Jurczyszyn A; Janz S; Beksac M; Gu C; Yang Y
    Cell Death Dis; 2021 Feb; 12(2):206. PubMed ID: 33627630
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Dihydrotestosterone synthesis bypasses testosterone to drive castration-resistant prostate cancer.
    Chang KH; Li R; Papari-Zareei M; Watumull L; Zhao YD; Auchus RJ; Sharifi N
    Proc Natl Acad Sci U S A; 2011 Aug; 108(33):13728-33. PubMed ID: 21795608
    [TBL] [Abstract][Full Text] [Related]  

  • 24. SRD5A1 and SRD5A2 are associated with treatment for benign prostatic hyperplasia with the combination of 5α-reductase inhibitors and α-adrenergic receptor antagonists.
    Gu X; Na R; Huang T; Wang L; Tao S; Tian L; Chen Z; Jiao Y; Kang J; Zheng S; Xu J; Sun J; Qi J
    J Urol; 2013 Aug; 190(2):615-9. PubMed ID: 23499746
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Androgenic correlates of genetic variation in the gene encoding 5alpha-reductase type 1.
    Ellis JA; Panagiotopoulos S; Akdeniz A; Jerums G; Harrap SB
    J Hum Genet; 2005; 50(10):534-537. PubMed ID: 16155734
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Caffeic acid N-[3,5-bis(trifluoromethyl)phenyl] amide as a non-steroidal inhibitor for steroid 5α-reductase type 1 using a human keratinocyte cell-based assay and molecular dynamics.
    Lin ACK; Netcharoensirisuk P; Sanachai K; Sukma W; Chansriniyom C; Chaotham C; De-Eknamkul W; Rungrotmongkol T; Chamni S
    Sci Rep; 2022 Dec; 12(1):20858. PubMed ID: 36460729
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Adverse PFAS effects on mouse oocyte in vitro maturation are associated with carbon-chain length and inclusion of a sulfonate group.
    Feng J; Soto-Moreno EJ; Prakash A; Balboula AZ; Qiao H
    Cell Prolif; 2023 Feb; 56(2):e13353. PubMed ID: 36305033
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Stimulatory effect of insulin on 5alpha-reductase type 1 (SRD5A1) expression through an Akt-dependent pathway in ovarian granulosa cells.
    Kayampilly PP; Wanamaker BL; Stewart JA; Wagner CL; Menon KM
    Endocrinology; 2010 Oct; 151(10):5030-7. PubMed ID: 20810561
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effect-Directed Analysis Based on Transthyretin Binding Activity of Per- and Polyfluoroalkyl Substances in a Contaminated Sediment Extract.
    Langberg HA; Choyke S; Hale SE; Koekkoek J; Cenijn PH; Lamoree MH; Rundberget T; Jartun M; Breedveld GD; Jenssen BM; Higgins CP; Hamers T
    Environ Toxicol Chem; 2024 Feb; 43(2):245-258. PubMed ID: 37888867
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Oxidation of Per- and Polyfluoroalkyl Ether Acids and Other Per- and Polyfluoroalkyl Substances by Sulfate and Hydroxyl Radicals: Kinetic Insights from Experiments and Models.
    Zhang C; Tang T; Knappe DRU
    Environ Sci Technol; 2023 Nov; 57(47):18970-18980. PubMed ID: 37223990
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Hamster SRD5A3 lacks steroid 5α-reductase activity in vitro.
    Chávez B; Ramos L; García-Becerra R; Vilchis F
    Steroids; 2015 Feb; 94():41-50. PubMed ID: 25498908
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Investigating the cytotoxicity of per- and polyfluoroalkyl substances in HepG2 cells: A structure-activity relationship approach.
    Amstutz VH; Cengo A; Gehres F; Sijm DTHM; Vrolijk MF
    Toxicology; 2022 Oct; 480():153312. PubMed ID: 36075290
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Localization of brain 5α-reductase messenger RNA in mice selectively bred for high chronic alcohol withdrawal severity.
    Roselli CE; Finn TJ; Ronnekleiv-Kelly SM; Tanchuck MA; Kaufman KR; Finn DA
    Alcohol; 2011 Dec; 45(8):763-72. PubMed ID: 21917407
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Carbon Chain Length Determines Inhibitory Potency of Perfluoroalkyl Sulfonic Acids on Human Placental 3β-Hydroxysteroid Dehydrogenase 1: Screening, Structure-Activity Relationship, and
    Tang LM; Mao BP; Zhang BR; Li JJ; Tang YB; Li HT; Ge RS
    Biomed Environ Sci; 2023 Nov; 36(11):1015-1027. PubMed ID: 38098322
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Perfluoroalkyl and polyfluoroalkyl substances (PFAS) and their effects on the ovary.
    Ding N; Harlow SD; Randolph JF; Loch-Caruso R; Park SK
    Hum Reprod Update; 2020 Sep; 26(5):724-752. PubMed ID: 32476019
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Site-directed mutagenesis studies of the NADPH-binding domain of rat steroid 5alpha-reductase (isozyme-1) I: analysis of aromatic and hydroxylated amino acid residues.
    Wang M; Bhattacharyya AK; Taylor MF; Tai HH; Collins DC
    Steroids; 1999 May; 64(5):356-62. PubMed ID: 10406485
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Mutational analysis of SRD5A2: From gene to functional kinetics in individuals with steroid 5α-reductase 2 deficiency.
    Ramos L; Vilchis F; Chávez B; Mares L
    J Steroid Biochem Mol Biol; 2020 Jun; 200():105691. PubMed ID: 32380235
    [TBL] [Abstract][Full Text] [Related]  

  • 38. How the Structure of Per- and Polyfluoroalkyl Substances (PFAS) Influences Their Binding Potency to the Peroxisome Proliferator-Activated and Thyroid Hormone Receptors-An In Silico Screening Study.
    Kowalska D; Sosnowska A; Bulawska N; Stępnik M; Besselink H; Behnisch P; Puzyn T
    Molecules; 2023 Jan; 28(2):. PubMed ID: 36677537
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Synthesis, Biological Evaluation and Molecular Docking of Avicequinone C Analogues as Potential Steroid 5α-Reductase Inhibitors.
    Karnsomwan W; Netcharoensirisuk P; Rungrotmongkol T; De-Eknamkul W; Chamni S
    Chem Pharm Bull (Tokyo); 2017; 65(3):253-260. PubMed ID: 28250347
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Per- and polyfluoroalkyl substances and volatile methyl siloxanes in global air: Spatial and temporal trends.
    Saini A; Chinnadurai S; Schuster JK; Eng A; Harner T
    Environ Pollut; 2023 Apr; 323():121291. PubMed ID: 36796663
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.